Innovative ETFs Content Hub Specialized Biotech ETF Rallies on MacroGenics Positive Trial Results By Max ChenFebruary 6, 2019
Core Equity Content Hub Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook By Max ChenJanuary 23, 2019
Leveraged & Inverse Content Hub Rising U.S. Health Care Spending a Boon to this Leveraged ETF By Ben HernandezJanuary 8, 2019
Equity ETFs Biotech ETFs Pop as Bristol-Myers Squibb Set to Acquire Celgene By Max ChenJanuary 3, 2019
Equity ETFs Healthcare ETFs Looked Pale on Reports J&J Knew About Asbestos in Baby Powder By Max ChenDecember 14, 2018
Equity ETFs ETFs to Help Investors Pick and Choose Their Market Exposures By Max ChenNovember 29, 2018
Leveraged & Inverse Content Hub Leveraged Healthcare ETF Gains On Midterm Election Results By Ben HernandezNovember 7, 2018
Leveraged & Inverse Content Hub 3 Midterm Election Issues that Could Move Leveraged Healthcare ETF By Ben HernandezNovember 6, 2018
Advisor Solutions Content Hub Health Care ETFs Retreat on DOJ Approval of Aetna-CVS Merger By Ben HernandezOctober 10, 2018
